Kimberly Moser
RN, BSN, State Representative
Kentucky, 64th District
Rep. Kim Moser is a Registered Nurse, with many years of experience in Neonatal Intensive Care Units and flight nursing on the University of Kentucky Neonatal Transport Team. She has dedicated her professional career to advocating for positive healthcare legislation and public health issues. Moser chaired the Kentucky Physician’s PAC, and worked with the Kentucky Medical Association Alliance on medical legislative issues. She is a past-president of the Kentucky Medical Association Alliance and is the current President of the AMA Alliance. She serves as Director of Drug Control Policy in northern Kentucky. In 2016, she was elected to the Kentucky legislature, where she serves on the Health and Family Services, Education, Licensing and Occupation, and Judiciary Committees and chairs the Medicaid Oversight and Advisory Committee. In her first legislative session, Moser successfully passed important legislation to limit opioid prescribing. She works to stem the tide of addiction through furthering best-practice policies in education and prevention, expanding addiction treatment, criminal justice reform and building model continuums.
Knowledge and Agility: Pivoting in Response to Federal and State Health Policy Changes
RN, BSN, State Representative
Kentucky, 64th District
Rep. Kim Moser is a Registered Nurse, with many years of experience in Neonatal Intensive Care Units and flight nursing on the University of Kentucky Neonatal Transport Team. She has dedicated her professional career to advocating for positive healthcare legislation and public health issues. Moser chaired the Kentucky Physician’s PAC, and worked with the Kentucky Medical Association Alliance on medical legislative issues. She is a past-president of the Kentucky Medical Association Alliance and is the current President of the AMA Alliance. She serves as Director of Drug Control Policy in northern Kentucky. In 2016, she was elected to the Kentucky legislature, where she serves on the Health and Family Services, Education, Licensing and Occupation, and Judiciary Committees and chairs the Medicaid Oversight and Advisory Committee. In her first legislative session, Moser successfully passed important legislation to limit opioid prescribing. She works to stem the tide of addiction through furthering best-practice policies in education and prevention, expanding addiction treatment, criminal justice reform and building model continuums.
Knowledge and Agility: Pivoting in Response to Federal and State Health Policy Changes
Steve Mullenix
Senior Vice President
National Council for Prescription Drug Programs
Steve Mullenix joined the National Council for Prescription Drug Programs in June 2009 and currently serves as senior vice president of public policy and industry relations. Previously, Mullenix served as director of professional and trade relations for Covidien/Mallinckrodt Pharmaceuticals. He also served as vice president of managed care and professional services with Medicap Pharmacies, Inc., a national pharmacy franchise organization. He is the former executive vice president of Q-A, Inc., a national drug utilization review and pharmacy consulting company. Mullenix also served as vice president and chief operating officer for the Iowa Pharmacy Association and its for-profit subsidiary.
The Intersection of Health IT and Opioid Misuse: Implementing a Real-Time Patient Safety System - Hosted by Health IT Now
Senior Vice President
National Council for Prescription Drug Programs
Steve Mullenix joined the National Council for Prescription Drug Programs in June 2009 and currently serves as senior vice president of public policy and industry relations. Previously, Mullenix served as director of professional and trade relations for Covidien/Mallinckrodt Pharmaceuticals. He also served as vice president of managed care and professional services with Medicap Pharmacies, Inc., a national pharmacy franchise organization. He is the former executive vice president of Q-A, Inc., a national drug utilization review and pharmacy consulting company. Mullenix also served as vice president and chief operating officer for the Iowa Pharmacy Association and its for-profit subsidiary.
The Intersection of Health IT and Opioid Misuse: Implementing a Real-Time Patient Safety System - Hosted by Health IT Now
Stanley Murzynski
MS, Clinical Website Administrator
Illinois Prescription Monitoring Program
Stanley Murzynski is the Clinical Website Administrator for the Illinois Prescription Monitoring Program. He received both his bachelor's and master's degrees in computer science from the University of Illinois, Springfield. He currently is pursuing a master's degree in healthcare informatics at the University of Illinois, Chicago. He has been with the Illinois Prescription Monitoring Program for six years and has held various I.T. positions during that time.
Advancing Science Into Action: Enhancing PDMPs and EHRs
MS, Clinical Website Administrator
Illinois Prescription Monitoring Program
Stanley Murzynski is the Clinical Website Administrator for the Illinois Prescription Monitoring Program. He received both his bachelor's and master's degrees in computer science from the University of Illinois, Springfield. He currently is pursuing a master's degree in healthcare informatics at the University of Illinois, Chicago. He has been with the Illinois Prescription Monitoring Program for six years and has held various I.T. positions during that time.
Advancing Science Into Action: Enhancing PDMPs and EHRs
Rebecca Naumann
PhD, MSPH, Epidemiologist
University of North Carolina at Chapel Hill
Becky Naumann, PhD, is an Injury Epidemiologist at the University of North Carolina at Chapel Hill. She has a bachelor's degree in environmental health (University of Georgia) and a master's degree in public health (Emory University). Prior to beginning her doctoral training in injury epidemiology, she worked as an epidemiologist in the National Center for Injury Prevention and Control at the Centers for Disease Control and Prevention. Naumann has engaged in injury prevention research for more than 10 years. She has published 25 articles in the field of injury prevention and co-authored four book chapters. She works as an Epidemiologist at the University of North Carolina's Injury Prevention Research Center, where she is involved in a variety of research projects related to opioid overdose prevention.
The Lock-In Loophole: Intended and Unintended Effects of Patient Review and Restriction Programs
PhD, MSPH, Epidemiologist
University of North Carolina at Chapel Hill
Becky Naumann, PhD, is an Injury Epidemiologist at the University of North Carolina at Chapel Hill. She has a bachelor's degree in environmental health (University of Georgia) and a master's degree in public health (Emory University). Prior to beginning her doctoral training in injury epidemiology, she worked as an epidemiologist in the National Center for Injury Prevention and Control at the Centers for Disease Control and Prevention. Naumann has engaged in injury prevention research for more than 10 years. She has published 25 articles in the field of injury prevention and co-authored four book chapters. She works as an Epidemiologist at the University of North Carolina's Injury Prevention Research Center, where she is involved in a variety of research projects related to opioid overdose prevention.
The Lock-In Loophole: Intended and Unintended Effects of Patient Review and Restriction Programs
Douglas (Doug) Nemecek MD, MBA
Chief Medical Officer
Cigna
Doug Nemecek, MD, MBA is the chief medical liaison for behavioral health integration, quality and clinical operations. He helps ensure network access and availability, patient safety, compliance with clinical guidelines, customer and provider satisfaction, and utilization management. Additionally, he works directly with customers and clients to mold operations and provides clinical expertise in new and existing behavioral health and integrated program development. Nemecek also leads Cigna’s national Coverage Policy team, responsible for developing policies and tools that are used to interpret standard medical, behavioral, and pharmacy benefit plan provisions. Additionally, he helps to coordinate Cigna’s national medical cost trend analysis and initiatives to address major medical cost drivers for our clients.
Health Plans Address America’s Opioid Epidemic with Evidence-Based Strategies
Improving the Quality of Substance Use Disorder Treatment through Payer-Driven Change
Chief Medical Officer
Cigna
Doug Nemecek, MD, MBA is the chief medical liaison for behavioral health integration, quality and clinical operations. He helps ensure network access and availability, patient safety, compliance with clinical guidelines, customer and provider satisfaction, and utilization management. Additionally, he works directly with customers and clients to mold operations and provides clinical expertise in new and existing behavioral health and integrated program development. Nemecek also leads Cigna’s national Coverage Policy team, responsible for developing policies and tools that are used to interpret standard medical, behavioral, and pharmacy benefit plan provisions. Additionally, he helps to coordinate Cigna’s national medical cost trend analysis and initiatives to address major medical cost drivers for our clients.
Health Plans Address America’s Opioid Epidemic with Evidence-Based Strategies
Improving the Quality of Substance Use Disorder Treatment through Payer-Driven Change
Kim Nesbitt
MA, Public Health Advisor/West Team, Center for Substance Abuse Prevention
Substance Abuse and Mental Health Service Administration
Kim Nesbitt is currently a Government Project Officer with the Substance Abuse and Mental Health Service Administration (SAMHSA), Center for Substance Abuse Prevention. At SAMHSA, Nesbitt is responsible for development of Funding Opportunity Announcements, oversees several discretionary grant programs and serves as Contract Officer Representative. She provides program expertise and guidance on public health programs in the field of substance abuse prevention. She previously worked as a Program Analyst with the Administration for Children and Families, Office of Community Services, Division of State Assistance, where she provided oversight and management of the Social Service Block Grant Hurricane Sandy program. She is a former Health Specialist at the National Institutes of Health, National Center for Complementary and Alternative Medicine, where she conducted portfolio analysis of programs and coordinated many facets of the extramural research office grant programs. Nesbitt has over 15 years of experience in the public health sector with expertise in research study coordination, grant monitoring and program development. She holds a master's degree in community health education from Adelphi University, a bachelor's degree in psychology from the State University of New York, and an associate’s degree in nursing from Howard Community College.
SAMHSA Opioid STR: State-Specific, Evidenced-Based Approaches to Prevention, Treatment and Recovery Support to Reduce Opioid Related Deaths
MA, Public Health Advisor/West Team, Center for Substance Abuse Prevention
Substance Abuse and Mental Health Service Administration
Kim Nesbitt is currently a Government Project Officer with the Substance Abuse and Mental Health Service Administration (SAMHSA), Center for Substance Abuse Prevention. At SAMHSA, Nesbitt is responsible for development of Funding Opportunity Announcements, oversees several discretionary grant programs and serves as Contract Officer Representative. She provides program expertise and guidance on public health programs in the field of substance abuse prevention. She previously worked as a Program Analyst with the Administration for Children and Families, Office of Community Services, Division of State Assistance, where she provided oversight and management of the Social Service Block Grant Hurricane Sandy program. She is a former Health Specialist at the National Institutes of Health, National Center for Complementary and Alternative Medicine, where she conducted portfolio analysis of programs and coordinated many facets of the extramural research office grant programs. Nesbitt has over 15 years of experience in the public health sector with expertise in research study coordination, grant monitoring and program development. She holds a master's degree in community health education from Adelphi University, a bachelor's degree in psychology from the State University of New York, and an associate’s degree in nursing from Howard Community College.
SAMHSA Opioid STR: State-Specific, Evidenced-Based Approaches to Prevention, Treatment and Recovery Support to Reduce Opioid Related Deaths
Elizabeth Nichols
MS, Manager, Department of Specialty Courts
Kentucky Administrative Office of the Courts, and Member, Operation UNITE Board of Directors
Elizabeth Nichols has served as a Manager for the Kentucky Department of Specialty Courts since 2012. She graduated with her masters’ degree from Eastern Kentucky University in criminal justice and police studies. She received her undergraduate diploma in political science and criminology from Western Kentucky University. Nichols is a NADCP member, Kentucky ASAP board member and alumnus of Kentucky Leadership Shelby.
MS, Manager, Department of Specialty Courts
Kentucky Administrative Office of the Courts, and Member, Operation UNITE Board of Directors
Elizabeth Nichols has served as a Manager for the Kentucky Department of Specialty Courts since 2012. She graduated with her masters’ degree from Eastern Kentucky University in criminal justice and police studies. She received her undergraduate diploma in political science and criminology from Western Kentucky University. Nichols is a NADCP member, Kentucky ASAP board member and alumnus of Kentucky Leadership Shelby.
Rita Noonan
PhD, Branch Chief, Division of Unintentional Injury Prevention
Centers for Disease Control and Prevention
Rita K. Noonan, PhD, is a sociologist and Branch Chief in the Centers for Disease Control and Prevention's Division of Unintentional Injury Prevention. Noonan and her staff oversee the $125 million Overdose Prevention in States (OPIS) initiative, a combination of prevention, intervention and public health surveillance programs to reduce opioid-related overdose across the United States. She works closely with several High Intensity Drug Trafficking Areas (HIDTAs), managing the public health component of Office of National Drug Control Policy's Heroin Response Strategy, which links public health and public safety across 22 states. She has been the recipient of several prestigious awards, including a Fulbright Scholarship and a MacArthur Fellowship. She received her doctorate degree from Indiana University.
Takeaways from the HIDTA/CDC Heroin Response Strategy and an Assessment of 911 Good Samaritan Laws
PhD, Branch Chief, Division of Unintentional Injury Prevention
Centers for Disease Control and Prevention
Rita K. Noonan, PhD, is a sociologist and Branch Chief in the Centers for Disease Control and Prevention's Division of Unintentional Injury Prevention. Noonan and her staff oversee the $125 million Overdose Prevention in States (OPIS) initiative, a combination of prevention, intervention and public health surveillance programs to reduce opioid-related overdose across the United States. She works closely with several High Intensity Drug Trafficking Areas (HIDTAs), managing the public health component of Office of National Drug Control Policy's Heroin Response Strategy, which links public health and public safety across 22 states. She has been the recipient of several prestigious awards, including a Fulbright Scholarship and a MacArthur Fellowship. She received her doctorate degree from Indiana University.
Takeaways from the HIDTA/CDC Heroin Response Strategy and an Assessment of 911 Good Samaritan Laws
Edward Nunes
MD, Professor of Psychiatry
Columbia University Medical Center / New York State Psychiatric Institute
Dr. Edward Nunes is a Professor of Psychiatry, and Principal Investigator of the Greater New York Node of the National Institute on Drug Abuse (NIDA) Clinical Trials Network, as well as other NIDA-funded studies on behavioral and medication treatments for substance dependence and related psychiatric disorders. Interests and ongoing studies include treatments for cocaine dependence in general, heroin and other opioid dependence, for nicotine dependence in general, and for addicted patients with co-occurring psychiatric disorders including depression, and post-traumatic stress disorder. Types of treatment under study include medication treatments (naltrexone, buprenorphine, mirtazapine), as well as behavioral and psychotherapeutic approaches and computer-delivered treatments. Nunes also studies the challenges involved in implementing evidence-based treatments for substance use disorders in real-world community-based treatments settings. Nunes serves on the American Board of Addiction Medicine, co-chairs the Columbia/New York State Psychiatric Institute’s Institutional Review Board, and has been appointed to the National Advisory Council on Drug Abuse.
Extended-Release Naltrexone vs. Buprenorphine-Naloxone: A Comparative Effectiveness Trial
MD, Professor of Psychiatry
Columbia University Medical Center / New York State Psychiatric Institute
Dr. Edward Nunes is a Professor of Psychiatry, and Principal Investigator of the Greater New York Node of the National Institute on Drug Abuse (NIDA) Clinical Trials Network, as well as other NIDA-funded studies on behavioral and medication treatments for substance dependence and related psychiatric disorders. Interests and ongoing studies include treatments for cocaine dependence in general, heroin and other opioid dependence, for nicotine dependence in general, and for addicted patients with co-occurring psychiatric disorders including depression, and post-traumatic stress disorder. Types of treatment under study include medication treatments (naltrexone, buprenorphine, mirtazapine), as well as behavioral and psychotherapeutic approaches and computer-delivered treatments. Nunes also studies the challenges involved in implementing evidence-based treatments for substance use disorders in real-world community-based treatments settings. Nunes serves on the American Board of Addiction Medicine, co-chairs the Columbia/New York State Psychiatric Institute’s Institutional Review Board, and has been appointed to the National Advisory Council on Drug Abuse.
Extended-Release Naltrexone vs. Buprenorphine-Naloxone: A Comparative Effectiveness Trial
Lyn Moore O’Connell
PhD, IMFT, SBIRT Clinical Coordinator
Marshall University
Dr. Lyn O’Connell is the Clinical Coordinator of the Screening, Brief Intervention and Referral to Treatment (SBIRT) grant at Marshall University. The SBIRT grant trains Marshall faculty and students along with community members on universal screening, motivational interviewing techniques, and evidence-based interventions to improve referrals to effective treatment. She received her doctorate from Virginia Tech in marriage and family therapy and her research focuses on barriers to accessing mental health treatment, stigma, motivation to change and substance use disorders in families.
Using What We Know: Helping Teachers, Families and Communities Respond Systematically to Children Affected by Familial SUD
PhD, IMFT, SBIRT Clinical Coordinator
Marshall University
Dr. Lyn O’Connell is the Clinical Coordinator of the Screening, Brief Intervention and Referral to Treatment (SBIRT) grant at Marshall University. The SBIRT grant trains Marshall faculty and students along with community members on universal screening, motivational interviewing techniques, and evidence-based interventions to improve referrals to effective treatment. She received her doctorate from Virginia Tech in marriage and family therapy and her research focuses on barriers to accessing mental health treatment, stigma, motivation to change and substance use disorders in families.
Using What We Know: Helping Teachers, Families and Communities Respond Systematically to Children Affected by Familial SUD
Julie O'Donnell
PhD, MPH, Epidemiologist
Centers for Disease Control and Prevention
Dr. Julie O’Donnell is an Epidemiologist on the Epidemiology and Surveillance Team in the Division of Unintentional Injury Prevention (DUIP) at the National Center for Injury Prevention and Control in the Centers for Disease Control and Prevention, working on the Enhanced State Opioid Overdose Surveillance (ESOOS) program. She is a subject matter expert working on the mortality data component of ESOOS and serves as the Science Officer for several funded states. O’Donnell served as an Epidemic Intelligence Service Officer at the Substance Abuse and Mental Health Services Administration prior to joining DUIP. As an Epidemic Intelligence Service Officer, she conducted field investigations and epidemiologic studies of behavioral health issues, including opioid overdose.
Faster Data: The CDC-Funded Enhanced State Opioid Overdose Surveillance Program
Opioid and Fentanyl Overdoses: Rapid Surveillance and Regional Patterns
PhD, MPH, Epidemiologist
Centers for Disease Control and Prevention
Dr. Julie O’Donnell is an Epidemiologist on the Epidemiology and Surveillance Team in the Division of Unintentional Injury Prevention (DUIP) at the National Center for Injury Prevention and Control in the Centers for Disease Control and Prevention, working on the Enhanced State Opioid Overdose Surveillance (ESOOS) program. She is a subject matter expert working on the mortality data component of ESOOS and serves as the Science Officer for several funded states. O’Donnell served as an Epidemic Intelligence Service Officer at the Substance Abuse and Mental Health Services Administration prior to joining DUIP. As an Epidemic Intelligence Service Officer, she conducted field investigations and epidemiologic studies of behavioral health issues, including opioid overdose.
Faster Data: The CDC-Funded Enhanced State Opioid Overdose Surveillance Program
Opioid and Fentanyl Overdoses: Rapid Surveillance and Regional Patterns
Nicole O'Kane
PharmD, Clinical Director
HealthInsight Oregon
Nicole O’Kane, PharmD, is a pharmacist and the Clinical Director at HealthInsight Oregon. Her expertise includes the evaluation and reporting of medical data, as well as the design and measurement of person-centered interventions to improve the safety and effectiveness of medication use. O’Kane has extensive experience collaborating with communities across Oregon to evaluate the incidence of harm related to adverse drug events, and support the integration of processes to improve medication safety. She works directly with providers and pharmacists across healthcare settings to provide leadership and project management to improve coordination of care for people taking high-risk medication combinations, including opioids and other controlled substances. O’Kane is a serving member of the Oregon Health Authority naloxone workgroup and the Tri-county opioid safety coalition, supporting the development of effective policies and monitoring for safer opioid prescribing and the expanded distribution of naloxone. She also serves as Co-Investigator on a project funded by Agency for Healthcare Research and Quality to develop and evaluate a toolkit aimed at community pharmacists to facilitate use of the Oregon Prescription Drug Monitoring Program and enhance supportive, effective communication between patients, pharmacists and prescribers around opioid management.
Pharmacy-Based Naloxone: Strategies from Massachusetts, Rhode Island, Oregon and Washington
Safe Rx Opioid and Naloxone Dispensing Toolkit: Pilot Study Results
PharmD, Clinical Director
HealthInsight Oregon
Nicole O’Kane, PharmD, is a pharmacist and the Clinical Director at HealthInsight Oregon. Her expertise includes the evaluation and reporting of medical data, as well as the design and measurement of person-centered interventions to improve the safety and effectiveness of medication use. O’Kane has extensive experience collaborating with communities across Oregon to evaluate the incidence of harm related to adverse drug events, and support the integration of processes to improve medication safety. She works directly with providers and pharmacists across healthcare settings to provide leadership and project management to improve coordination of care for people taking high-risk medication combinations, including opioids and other controlled substances. O’Kane is a serving member of the Oregon Health Authority naloxone workgroup and the Tri-county opioid safety coalition, supporting the development of effective policies and monitoring for safer opioid prescribing and the expanded distribution of naloxone. She also serves as Co-Investigator on a project funded by Agency for Healthcare Research and Quality to develop and evaluate a toolkit aimed at community pharmacists to facilitate use of the Oregon Prescription Drug Monitoring Program and enhance supportive, effective communication between patients, pharmacists and prescribers around opioid management.
Pharmacy-Based Naloxone: Strategies from Massachusetts, Rhode Island, Oregon and Washington
Safe Rx Opioid and Naloxone Dispensing Toolkit: Pilot Study Results
Gina Olberding
MBA, Operations Manager
Colorado Consortium for Prescription Drug Abuse Prevention
Gina Olberding is the Operations Manager for the Colorado Consortium for Prescription Drug Abuse Prevention. Created by Gov. Hickenlooper in 2013, the consortium addresses Rx drug abuse with a collaborative, statewide approach, serving as the convener for 10 work groups with over 400 members. Prior, Olberding spent nearly 12 years in patient safety and risk management at COPIC Insurance, managing a nationally recognized communication and reimbursement program designed to address unanticipated medical outcomes. She is a volunteer and past board secretary for the Colorado nonprofit Kids in Need of Dentistry. She has a Master of Business Administration in healthcare administration.
Colorado AmeriCorps Community Opioid Response Program
United We Stand: Georgia’s Comprehensive Plan and Colorado’s Collective Impact Model
MBA, Operations Manager
Colorado Consortium for Prescription Drug Abuse Prevention
Gina Olberding is the Operations Manager for the Colorado Consortium for Prescription Drug Abuse Prevention. Created by Gov. Hickenlooper in 2013, the consortium addresses Rx drug abuse with a collaborative, statewide approach, serving as the convener for 10 work groups with over 400 members. Prior, Olberding spent nearly 12 years in patient safety and risk management at COPIC Insurance, managing a nationally recognized communication and reimbursement program designed to address unanticipated medical outcomes. She is a volunteer and past board secretary for the Colorado nonprofit Kids in Need of Dentistry. She has a Master of Business Administration in healthcare administration.
Colorado AmeriCorps Community Opioid Response Program
United We Stand: Georgia’s Comprehensive Plan and Colorado’s Collective Impact Model
Elizabeth Oliva
PhD, VA National Opioid Overdose Education and Naloxone Distribution Coordinator
Department of Veterans Affairs, Veterans Health Administration
Elizabeth Oliva, PhD, received her bachelor's degree in psychology and sociology from UCLA. She received her doctorate in clinical and developmental psychology from University of Minnesota, where her graduate work was funded by a National Science Foundation Graduate Fellowship. Oliva completed her pre-doctoral clinical psychology internship at UCSD/VA San Diego and, since then, has worked for the VA Office of Mental Health and Suicide Prevention. She is currently the VA National Opioid Overdose Education and Naloxone Distribution (OEND) Coordinator and is also a Core Investigator at the VA Center for Innovation to Implementation. Oliva chairs the VA workgroup that developed the national OEND implementation and evaluation plan, was Principal Investigator on a VA grant that evaluated initial implementation of OEND within two Veterans Integrated Service Networks, and was recently awarded another VA grant to evaluate the effectiveness of naloxone distribution within VA. She was also a Co-Investigator on a VA grant that developed and evaluated a multi-faceted intervention to improve access to pharmacological treatments for alcohol dependence. Oliva also serves as an Associate Editor for the journal Substance Abuse.
VA Best Practices: S.T.O.P. P.A.I.N Initiative and Practice Guidelines
VA Data about Rx Opioids and Overdose and Suicide: Clinical Implications
PhD, VA National Opioid Overdose Education and Naloxone Distribution Coordinator
Department of Veterans Affairs, Veterans Health Administration
Elizabeth Oliva, PhD, received her bachelor's degree in psychology and sociology from UCLA. She received her doctorate in clinical and developmental psychology from University of Minnesota, where her graduate work was funded by a National Science Foundation Graduate Fellowship. Oliva completed her pre-doctoral clinical psychology internship at UCSD/VA San Diego and, since then, has worked for the VA Office of Mental Health and Suicide Prevention. She is currently the VA National Opioid Overdose Education and Naloxone Distribution (OEND) Coordinator and is also a Core Investigator at the VA Center for Innovation to Implementation. Oliva chairs the VA workgroup that developed the national OEND implementation and evaluation plan, was Principal Investigator on a VA grant that evaluated initial implementation of OEND within two Veterans Integrated Service Networks, and was recently awarded another VA grant to evaluate the effectiveness of naloxone distribution within VA. She was also a Co-Investigator on a VA grant that developed and evaluated a multi-faceted intervention to improve access to pharmacological treatments for alcohol dependence. Oliva also serves as an Associate Editor for the journal Substance Abuse.
VA Best Practices: S.T.O.P. P.A.I.N Initiative and Practice Guidelines
VA Data about Rx Opioids and Overdose and Suicide: Clinical Implications
Whit Oyler
Program Manager
Colorado Consortium for Prescription Drug Abuse Prevention
Whit Oyler is the Program Manager for the Colorado Consortium for Prescription Drug Abuse Prevention, a statewide collaborative of over 300 participants from state agencies, universities, professional associations, treatment centers and stakeholder groups. He is pursuing a Master of Public Health at the University of Colorado and is an alumnus of the Substance Abuse and Mental Health Services Administration Prevention Fellowship and was housed in the Colorado Department of Human Services – Office of Behavioral Health.
Safe Disposal in Colorado: A State-Led Approach
Program Manager
Colorado Consortium for Prescription Drug Abuse Prevention
Whit Oyler is the Program Manager for the Colorado Consortium for Prescription Drug Abuse Prevention, a statewide collaborative of over 300 participants from state agencies, universities, professional associations, treatment centers and stakeholder groups. He is pursuing a Master of Public Health at the University of Colorado and is an alumnus of the Substance Abuse and Mental Health Services Administration Prevention Fellowship and was housed in the Colorado Department of Human Services – Office of Behavioral Health.
Safe Disposal in Colorado: A State-Led Approach
Gary Ozanich
PhD, Director of Health Informatics, Associate Director of Research
Health Innovation Center, Northern Kentucky University
Gary Ozanich is Director of the Northern Kentucky University (NKU) Graduate Program in Health Informatics, and Associate Director of Research for NKU’s Health Innovation Center. He recently stepped down as the National Co-Chair of the Interoperability and Health Information Exchange Workgroup for the Health Information Systems Society (HIMSS) and was past National Chair of the HIMSS HIE Committee. He has conducted extensive funded research and consulting projects on the application of interoperability and data exchange to support care coordination and population health. This includes data integration through clinical decision support tools as they relate to workflow, outcomes, clinical inertia and patient engagement. Opioid-focused projects include integration of clinical, administrative and unstructured data for predictive analytics, and the study of barriers to care for chemically dependent pregnant women. Relative to other academic positions, he was Associate Director of the Institute of Tele-Information at Columbia University, and has been on the faculties of Michigan State University and University at Buffalo. He holds a doctorate degree from the University of Wisconsin-Madison.
PhD, Director of Health Informatics, Associate Director of Research
Health Innovation Center, Northern Kentucky University
Gary Ozanich is Director of the Northern Kentucky University (NKU) Graduate Program in Health Informatics, and Associate Director of Research for NKU’s Health Innovation Center. He recently stepped down as the National Co-Chair of the Interoperability and Health Information Exchange Workgroup for the Health Information Systems Society (HIMSS) and was past National Chair of the HIMSS HIE Committee. He has conducted extensive funded research and consulting projects on the application of interoperability and data exchange to support care coordination and population health. This includes data integration through clinical decision support tools as they relate to workflow, outcomes, clinical inertia and patient engagement. Opioid-focused projects include integration of clinical, administrative and unstructured data for predictive analytics, and the study of barriers to care for chemically dependent pregnant women. Relative to other academic positions, he was Associate Director of the Institute of Tele-Information at Columbia University, and has been on the faculties of Michigan State University and University at Buffalo. He holds a doctorate degree from the University of Wisconsin-Madison.
Denise Paone
EdD, Senior Director of Research and Surveillance
New York City Department of Health and Mental Hygience
Dr. Denise Paone is the Senior Director of Research and Surveillance in the Bureau of Alcohol and Drug Use Prevention, Care and Treatment at the New York City Department of Health and Mental Hygiene. She received her master's and doctoral degrees from Columbia University and has more than 25 years of experience in the fields of public health, harm reduction and substance use research. Before joining city government, Paone served as Director of Research at Beth Israel Chemical Dependency Institute, where she conducted several local, national and international drug and syringe exchange program evaluation studies. Paone is currently leading city-wide substance use and overdose surveillance, as well as conducting drug-related morbidity and mortality studies with an emphasis on overdose deaths and the fentanyl-driven opioid epidemic. She co-leads the real-time drug surveillance project RxStat, an innovative collaboration between public health and public safety that serves as a national model for jurisdictions struggling with high rates of drug overdose. Paone is a Distinguished Scholar affiliated with the CUNY School of Public Health, and the former chair of the National Council of State and Territorial Epidemiologists overdose subcommittee. She has published numerous research papers and peer-reviewed articles.
Fentanyl and the Overdose Epidemic: The NYC Public Health Response
EdD, Senior Director of Research and Surveillance
New York City Department of Health and Mental Hygience
Dr. Denise Paone is the Senior Director of Research and Surveillance in the Bureau of Alcohol and Drug Use Prevention, Care and Treatment at the New York City Department of Health and Mental Hygiene. She received her master's and doctoral degrees from Columbia University and has more than 25 years of experience in the fields of public health, harm reduction and substance use research. Before joining city government, Paone served as Director of Research at Beth Israel Chemical Dependency Institute, where she conducted several local, national and international drug and syringe exchange program evaluation studies. Paone is currently leading city-wide substance use and overdose surveillance, as well as conducting drug-related morbidity and mortality studies with an emphasis on overdose deaths and the fentanyl-driven opioid epidemic. She co-leads the real-time drug surveillance project RxStat, an innovative collaboration between public health and public safety that serves as a national model for jurisdictions struggling with high rates of drug overdose. Paone is a Distinguished Scholar affiliated with the CUNY School of Public Health, and the former chair of the National Council of State and Territorial Epidemiologists overdose subcommittee. She has published numerous research papers and peer-reviewed articles.
Fentanyl and the Overdose Epidemic: The NYC Public Health Response
Chauncey Parker
JD, Director
New York/New Jersey HIDTA, and Member, National Rx Drug Abuse & Heroin Summit Advisory Board
Chauncey Parker, JD, serves as the Director of the New York/New Jersey High Intensity Drug Trafficking Area (HIDTA), a federally-funded program that invests in public safety and public health partnerships designed to reduce drug abuse and its consequences. He also serves as Executive Assistant District Attorney for Crime Strategies in the Manhattan District Attorney’s Office. A veteran of more than 27 years in criminal justice, Parker began his career in the District Attorney’s Office in 1986, where he served for five years. He next served for 10 years as an Assistant U.S. Attorney for the Southern District of New York. In 2002, Gov. George Pataki appointed him to serve as the Director of Criminal Justice for New York State, where for five years he oversaw all state criminal justice agencies. Parker is a member of the National Rx Drug Abuse & Heroin Summit Advisory Board.
Data-Driven Initiatives to End Overdoses
Takeaways from the HIDTA/CDC Heroin Response Strategy and an Assessment of 911 Good Samaritan Laws
JD, Director
New York/New Jersey HIDTA, and Member, National Rx Drug Abuse & Heroin Summit Advisory Board
Chauncey Parker, JD, serves as the Director of the New York/New Jersey High Intensity Drug Trafficking Area (HIDTA), a federally-funded program that invests in public safety and public health partnerships designed to reduce drug abuse and its consequences. He also serves as Executive Assistant District Attorney for Crime Strategies in the Manhattan District Attorney’s Office. A veteran of more than 27 years in criminal justice, Parker began his career in the District Attorney’s Office in 1986, where he served for five years. He next served for 10 years as an Assistant U.S. Attorney for the Southern District of New York. In 2002, Gov. George Pataki appointed him to serve as the Director of Criminal Justice for New York State, where for five years he oversaw all state criminal justice agencies. Parker is a member of the National Rx Drug Abuse & Heroin Summit Advisory Board.
Data-Driven Initiatives to End Overdoses
Takeaways from the HIDTA/CDC Heroin Response Strategy and an Assessment of 911 Good Samaritan Laws
Stephanie M. Patton
MPH, Prevention Coordinator
Town of Stoughton, Massachusetts
Stephanie Patton, MPH, has been identified by her peers as a prevention leader in Massachusetts. She has been the Prevention Coordinator for the Organizing Against Substances in Stoughton (OASIS) Coalition since 2012, but involved with the coalition since its inception in 2004. A primary focus of her work is policy change at the local, regional and state level. Prior to this role, Patton served as the Program Director for the Southeast Center for Healthy Communities, where she provided technical assistance to prevention coalitions throughout Southeastern Massachusetts. Stephanie has over 15 years of experience in public health, substance abuse prevention and coalition development. She has presented at numerous national, state and regional conferences and has extensive experience developing and leading engaging workshops and trainings. atton has a master's degree in public health from the University of Massachusetts, Amherst and a bachelor's degree from Wellesley College.
Effective Early Primary Prevention for Rx Drug Abuse
MPH, Prevention Coordinator
Town of Stoughton, Massachusetts
Stephanie Patton, MPH, has been identified by her peers as a prevention leader in Massachusetts. She has been the Prevention Coordinator for the Organizing Against Substances in Stoughton (OASIS) Coalition since 2012, but involved with the coalition since its inception in 2004. A primary focus of her work is policy change at the local, regional and state level. Prior to this role, Patton served as the Program Director for the Southeast Center for Healthy Communities, where she provided technical assistance to prevention coalitions throughout Southeastern Massachusetts. Stephanie has over 15 years of experience in public health, substance abuse prevention and coalition development. She has presented at numerous national, state and regional conferences and has extensive experience developing and leading engaging workshops and trainings. atton has a master's degree in public health from the University of Massachusetts, Amherst and a bachelor's degree from Wellesley College.
Effective Early Primary Prevention for Rx Drug Abuse
Nick Peiper
PhD, MPH, Behavioral Epidemiologist
RTI International
Nicholas C. Peiper, PhD, MPH, is a Behavioral Scientist in RTI International's Behavioral and Urban Health Program, with 10 years of experience in substance use, mental health and clinical epidemiology. His current work with the Centers for Disease Control and Prevention (CDC) evaluates prescription drug monitoring programs, opioid overdose policies and medication assisted treatment programs. Through the Substance Abuse and Mental Health Services Administration (SAMHSA), he also investigates psychiatric comorbidity and service utilization among adults with serious mental illness. In a similar line of research, Peiper concentrates on the application of emergent computational methods to understand the epidemiology of cannabis use, including the intersection with opioids. As part of this work, he currently conducts Internet-mediated surveys to better understand quality of life outcomes among medical cannabis patients who substitute cannabis for Rx opioids and heroin. In addition, he holds an adjunct appointment in the Department of Epidemiology and Population Health at the University of Louisville, where he teaches online doctoral courses in behavioral epidemiology and applied research methodologies; directs practicum and internship programs; and mentors graduate students in public health and the social sciences.
Drug Checking: A Novel Evidence-Based Strategy for Preventing Overdose
PhD, MPH, Behavioral Epidemiologist
RTI International
Nicholas C. Peiper, PhD, MPH, is a Behavioral Scientist in RTI International's Behavioral and Urban Health Program, with 10 years of experience in substance use, mental health and clinical epidemiology. His current work with the Centers for Disease Control and Prevention (CDC) evaluates prescription drug monitoring programs, opioid overdose policies and medication assisted treatment programs. Through the Substance Abuse and Mental Health Services Administration (SAMHSA), he also investigates psychiatric comorbidity and service utilization among adults with serious mental illness. In a similar line of research, Peiper concentrates on the application of emergent computational methods to understand the epidemiology of cannabis use, including the intersection with opioids. As part of this work, he currently conducts Internet-mediated surveys to better understand quality of life outcomes among medical cannabis patients who substitute cannabis for Rx opioids and heroin. In addition, he holds an adjunct appointment in the Department of Epidemiology and Population Health at the University of Louisville, where he teaches online doctoral courses in behavioral epidemiology and applied research methodologies; directs practicum and internship programs; and mentors graduate students in public health and the social sciences.
Drug Checking: A Novel Evidence-Based Strategy for Preventing Overdose
